Cargando…
Newborn Screening for Pompe Disease
Glycogen storage disease type II (also known as Pompe disease (PD)) is an autosomal recessive disorder caused by defects in α-glucosidase (AαGlu), resulting in lysosomal glycogen accumulation in skeletal and heart muscles. Accumulation and tissue damage rates depend on residual enzyme activity. Enzy...
Autores principales: | Sawada, Takaaki, Kido, Jun, Nakamura, Kimitoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423004/ https://www.ncbi.nlm.nih.gov/pubmed/33073027 http://dx.doi.org/10.3390/ijns6020031 |
Ejemplares similares
-
Current status of newborn screening for Pompe disease in Japan
por: Sawada, Takaaki, et al.
Publicado: (2021) -
High-Risk Screening for Fabry Disease: A Nationwide Study in Japan and Literature Review
por: Sawada, Takaaki, et al.
Publicado: (2021) -
Newborn screening for Gaucher disease in Japan
por: Sawada, Takaaki, et al.
Publicado: (2022) -
Newborn screening for Fabry disease in the western region of Japan
por: Sawada, Takaaki, et al.
Publicado: (2020) -
Detection of novel Fabry disease‐associated pathogenic variants in Japanese patients by newborn and high‐risk screening
por: Sawada, Takaaki, et al.
Publicado: (2020)